https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hZGFwdGltbXVuZS10Y3ItdGhlcmFwZXV0aWNzLWFubm91bmNlLXN0cmF0ZWdpYy0xMTAwMDAzMDguaHRtbNIBZWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2FkYXB0aW1tdW5lLXRjci10aGVyYXBldXRpY3MtYW5ub3VuY2Utc3RyYXRlZ2ljLTExMDAwMDMwOC5odG1s?oc=5
Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors - Yahoo Finance